These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27345360)

  • 1. A previously unrecognized role of C3a in proteinuric progressive nephropathy.
    Morigi M; Locatelli M; Rota C; Buelli S; Corna D; Rizzo P; Abbate M; Conti D; Perico L; Longaretti L; Benigni A; Zoja C; Remuzzi G
    Sci Rep; 2016 Jun; 6():28445. PubMed ID: 27345360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans.
    Puelles VG; van der Wolde JW; Wanner N; Scheppach MW; Cullen-McEwen LA; Bork T; Lindenmeyer MT; Gernhold L; Wong MN; Braun F; Cohen CD; Kett MM; Kuppe C; Kramann R; Saritas T; van Roeyen CR; Moeller MJ; Tribolet L; Rebello R; Sun YB; Li J; Müller-Newen G; Hughson MD; Hoy WE; Person F; Wiech T; Ricardo SD; Kerr PG; Denton KM; Furic L; Huber TB; Nikolic-Paterson DJ; Bertram JF
    JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31534053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis.
    Eng DG; Sunseri MW; Kaverina NV; Roeder SS; Pippin JW; Shankland SJ
    Kidney Int; 2015 Nov; 88(5):999-1012. PubMed ID: 25993321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3a receptor blockade protects podocytes from injury in diabetic nephropathy.
    Morigi M; Perico L; Corna D; Locatelli M; Cassis P; Carminati CE; Bolognini S; Zoja C; Remuzzi G; Benigni A; Buelli S
    JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32161193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of parietal epithelial cell and podocyte extracellular matrix proteins in focal segmental glomerulosclerosis and diabetic nephropathy.
    Chan GC; Eng DG; Miner JH; Alpers CE; Hudkins K; Chang A; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1680-F1694. PubMed ID: 31630546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
    Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
    Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic MIF and SDF1 expression during podocyte injury promote CD44-mediated glomerular parietal cell migration in focal segmental glomerulosclerosis.
    Ito N; Sakamoto K; Hikichi C; Matsusaka T; Nagata M
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F741-F753. PubMed ID: 32068458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
    Raij L; Tian R; Wong JS; He JC; Campbell KN
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.
    Angeletti A; Cantarelli C; Petrosyan A; Andrighetto S; Budge K; D'Agati VD; Hartzell S; Malvi D; Donadei C; Thurman JM; Galešić-Ljubanović D; He JC; Xiao W; Campbell KN; Wong J; Fischman C; Manrique J; Zaza G; Fiaccadori E; La Manna G; Fribourg M; Leventhal J; Da Sacco S; Perin L; Heeger PS; Cravedi P
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32717081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing mTOR augments parietal epithelial cell density in a model of acute podocyte depletion and in aged kidneys.
    McNicholas BA; Eng DG; Lichtnekert J; Rabinowitz PS; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2016 Sep; 311(3):F626-39. PubMed ID: 27440779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
    Ohse T; Vaughan MR; Kopp JB; Krofft RD; Marshall CB; Chang AM; Hudkins KL; Alpers CE; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F702-11. PubMed ID: 20007346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking the stochastic fate of cells of the renin lineage after podocyte depletion using multicolor reporters and intravital imaging.
    Kaverina NV; Kadoya H; Eng DG; Rusiniak ME; Sequeira-Lopez ML; Gomez RA; Pippin JW; Gross KW; Peti-Peterdi J; Shankland SJ
    PLoS One; 2017; 12(3):e0173891. PubMed ID: 28329012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
    Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
    Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.
    Locatelli M; Buelli S; Pezzotta A; Corna D; Perico L; Tomasoni S; Rottoli D; Rizzo P; Conti D; Thurman JM; Remuzzi G; Zoja C; Morigi M
    J Am Soc Nephrol; 2014 Aug; 25(8):1786-98. PubMed ID: 24578132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis.
    Cruzado JM; Manonelles A; Rayego-Mateos S; Doladé N; Amaya-Garrido A; Varela C; Guiteras R; Mosquera JL; Jung M; Codina S; Martínez-Valenzuela L; Draibe J; Couceiro C; Vigués F; Madrid Á; Florian MC; Ruíz-Ortega M; Sola A
    Kidney Int; 2024 Jul; 106(1):67-84. PubMed ID: 38428734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial
    Luque Y; Lenoir O; Bonnin P; Hardy L; Chipont A; Placier S; Vandermeersch S; Xu-Dubois YC; Robin B; Lazareth H; Souyri M; Guyonnet L; Baudrie V; Camerer E; Rondeau E; Mesnard L; Tharaux PL
    J Am Soc Nephrol; 2017 Dec; 28(12):3563-3578. PubMed ID: 28928136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
    Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
    J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice.
    Smeets B; Te Loeke NA; Dijkman HB; Steenbergen ML; Lensen JF; Begieneman MP; van Kuppevelt TH; Wetzels JF; Steenbergen EJ
    J Am Soc Nephrol; 2004 Apr; 15(4):928-39. PubMed ID: 15034095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis.
    Kuppe C; Gröne HJ; Ostendorf T; van Kuppevelt TH; Boor P; Floege J; Smeets B; Moeller MJ
    Kidney Int; 2015 Nov; 88(5):990-8. PubMed ID: 25853334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.